Cell line · CVCL_1045
22Rv1
Cancer cell line, Homo sapiens. Prostate carcinoma. 217 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. 22Rv1. Cell lines, record CVCL_1045. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1045
On this page
Cell line
As Cellosaurus gives it.
- Name
- 22Rv1
- Accession
- CVCL_1045
- RRID
- RRID:CVCL_1045
- Synonyms
- 22RV1, 22Rv-1, 22rV1, CWR-22rv1, CWR22-Rv1, CWR22R-V1, CWR22-R1, CWR22Rv1, CWR22R
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- Adult
- Category
- Cancer cell line
- Diseases
- Prostate carcinoma (NCIt C4863)
- Derived from
- Prostate (in situ)
- Parent
- CWR22 (CVCL_3967)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers217
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| In vivo validation of intramolecular bivalent glues targeting PSMA reveals potent and tissue-selective BRD4 degradation in prostate cancer. | Acta Pharm Sin B | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Obesity-Induced PLPE-PTK6-FASN Feedback Loop Drives Enzalutamide Resistance by Exacerbating Lipid Metabolic Dysregulation in Castration-Resistant Prostate Cancer. | Research (Wash D C) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Castration-resistant prostate cancer cells are addicted to the high activity of cyclin-dependent kinase 2. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| SLPI is associated with AR-regulated epithelial adaptation and enzalutamide sensitivity in castration-resistant prostate cancer. | Front Pharmacol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Vitronectin Enrichment in Prostate Cancer Liver Metastases Promotes Adhesion and Survival. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Multi-omics dissection of FOXA1 reveals cancer-type-specific transcriptional networks and functional risk variants. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting Siglec-engaging immunosuppressive sialoglycans to suppress prostate cancer bone metastasis. | Br J Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR status. | Br J Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Lactate-induced H3K4me3 histone mark promotes PLOD1-driven prostate cancer invasion. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 217
See all 217 papersRelatives24
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | CWR22 | CVCL_3967 | Cell lines | |
| Derived from it | 22RV1-EGFP | CVCL_C8WA | Cell lines | |
| Derived from it | 22RV1-Luc | CVCL_C8UT | Cell lines | |
| Derived from it | 22RV1rYM155_300nM | CVCL_RS39 | Cell lines | |
| Derived from it | 22Rv1 CHD7 KO clone 2A2 | CVCL_E8SC | Cell lines | |
| Derived from it | 22Rv1 R | CVCL_4Y35 | Cell lines | |
| Derived from it | 22Rv1-CHD7 KO clone 1C2 | CVCL_E8SD | Cell lines | |
| Derived from it | 22Rv1-CabR1 | CVCL_A6PG | Cell lines | |
| Derived from it | 22Rv1-CabR2 | CVCL_A6PH | Cell lines | |
| Derived from it | 22Rv1-SL | CVCL_WZ28 | Cell lines |
1 to 10 of 24
See all 24 relativesCell banks9
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-2505 | ATCC | |
| BCRC | 60545 | BCRC | |
| CCTCC | GDC0288 | Cellosaurus | |
| CLS | 305037 | CLS | |
| DSMZ | ACC-438 | DSMZ | |
| ECACC | 05092802 | ECACC | |
| EDITGENE | EDC00358 | EDITGENE | |
| KCB | KCB 200731YJ | Cellosaurus | |
| Ubigene | YC-C012 | Ubigene |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1045
GET https://conductscience.org/api/cell-lines/v1/CVCL_1045/papers?page=2